Karam Ashouri

10PUBLICATIONS
36CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersMolecular targetsInnate immunityHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Aug 17, 2026
Dihydropyrimidine dehydrogenase modulates immune response to checkpoint inhibition in mismatch repair deficient/microsatellite instability-high colorectal cancer.

|Aug 08, 2026
Exploring PDLIM2 as a prognostic biomarker and therapeutic target in lung adenocarcinoma.

|Dec 21, 2025
Clinical and molecular characterization of AXL in colorectal cancer, CALGB (Alliance)/SWOG 80405 and real-world data.

Karam Ashouri, Joshua Millstein, Yan Yang

|Jul 04, 2025
Pan-RAS inhibitors and polo-like kinase 1: promising targets in colorectal cancer.

Priya Jayachandran, Andrew Elliott, Shivani Soni

|Apr 28, 2025
Association of Androgen Receptor Expression With Tumor Immune Landscape and Treatment Outcomes of Patients With Breast Cancer.

Priya Jayachandran, Sachin K Deshmukh, Sharon Wu

|Mar 27, 2025
Genetic Polymorphisms in MHC Classes I and II Predict Outcomes in Metastatic Colorectal Cancer.

Pooja Mittal, Francesca Battaglin, Yan Yang

Pageof 2

Frequent Collaborators

6 joint publications

Heinz-Josef Lenz

5 joint publications

Francesca Battaglin

3 joint publications

Joshua Millstein

3 joint publications

Sandra Algaze